Ep. 58 - Ysios' Karen Wagner: How Europe's Biotechs Can Rise Above the Noise
Description
It sounds obvious, but still needs saying, says Ysios Capital's Karen Wagner. “How do you rise above the noise? By having the most spectacular data.” In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Wagner discussed the theme of the upcoming Bio€quity Europe conference — rising above the noise: in a sea of competition where companies vie for attention among investors and pharmas, what are the characteristics that allow them to differentiate? Wagner explains what she and her team looks for in a biotech before investing, and also discusses the role of ESG policies, including diversity, in companies. “We have absolute certainty that ESG is important."
View full story: https://www.biocentury.com/article/652294
#biotech #biopharma #pharma #lifescience #finance
00:00 - Intro
01:36 - Spain’s Biotech Ecosystem
09:30 - Investment Criteria
14:27 - ESG, Diversity
27:53 - AI in Drug Development
United States
